Skip to main content

Table 3 Comparison between anthropometric and laboratory data in MetS and non-MetS obese patients

From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children

Anthropometric data

MetS (no. = 12)

Non-MetS (no. = 31)

p value

Height (SDS)

0.523 ± 0.971

0.325 ± 1.42

0.6

Weight (SDS)

3.41 ± 1.70

3.06 ± 1.47

0.5

BMI (kg/m2)

30.15 ± 3.29

29.15 ± 3.55

0.4

BMI (SDS)

3.23 ± 0.733

3.08 ± 0.560

0.5

Waist circumference (cm)

89.61 ± 9.16

85.21 ± 4.21

0.03*

Hip circumference (cm)

95.29 ± 10.48

90.96 ± 7.58

0.2

W/H ratio

0.939 ± 0.052

0.934 ± 0.054

0.8

Biceps skin fold (mm)

19.07 ± 5.32

18.75 ± 2.99

0.8

Triceps skin fold (mm)

26.23 ± 5.23

25.00 ± 3.28

0.5

Subscapular skin fold (mm)

25.25 ± 3.67

26.48 ± 5.46

0.5

Systolic Bp (mmHg)

121.42 ± 6.29

112.90 ± 8.92

0.001*

Diastolic Bp (mmHg)

82.92 ± 12.15

75.81 ± 10.89

0.04*

Total cholesterol (mg/dl)

171.94 ± 26.06

159.25 ± 33.32

0.2

Triglycerides (mg/dl)

125.83 ± 32.86

90.71 ± 21.92

0.000**

HDL-c (mg/dl)

40.08 ± 13.53

41.68 ± 9.87

0.8

LDL-c (mg/dl)

89.75 ± 43.91

108.19 ± 25.78

0.2

FBS (mg/dl)

103.08 ± 4.36

91.00 ± 8.80

0.000**

Insulin (μIU/ml)

19.31 ± 7.40

17.15 ± 8.35

0.4

HOMA-IR

4.89 ± 1.85

3.85 ± 1.93

0.1

PAI-1

55.67 ± 4.94

49.84 ± 4.52

0.02

  1. Comparisons between groups were done using ANOVA test
  2. **p value highly significant < 0.01